Registro de lesiones coronarias difusas tratadas con stents liberadores de fármacos ≥ 40 mm

Mehran, 2000, Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: Intravascular ultrasound study of 2256 patients, Circulation, 101, 604, 10.1161/01.CIR.101.6.604 Bahuleyan, 2015, Prospective study to evaluate safety and efficacy of Zotarolimus Eluting Stent (PSEZES) in patients with long coronary artery lesions, Indian Heart J., 67, 233, 10.1016/j.ihj.2015.03.014 Lee, 2014, Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions. A randomized long drug-eluting stent v trial, Circ Cardiovasc Interv, 7, 322, 10.1161/CIRCINTERVENTIONS.113.000841 Kastrati, 2006, Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents, Circulation, 113, 2293, 10.1161/CIRCULATIONAHA.105.601823 Park, 2011, Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial, JACC Cardiovasc Interv., 4, 1096, 10.1016/j.jcin.2011.05.024 Xu, 2012, TCT-607 clinical outcome in Chinese patients with long lesion or small vessel/multivessel disease receiving XIENCE V everolimus-eluting stent: Early results from the SEEDS study, JACC, 60, B176, 10.1016/j.jacc.2012.08.644 Costa, 2011, One year outcomes after implantation of Xience Prime long lesion stents in patients with coronary artery disease: Primary endpoint results of the SPIRIT PRIME multicentre clinical trial (abstract), J Am Coll Cardiol., 58, B217, 10.1016/j.jacc.2011.10.833 Polavarapu, 2015, Clinical outcomes from unselected “real-world” patients with long coronary lesion receiving 40 mm biodegradable polymer coated sirolimus-eluting stent, Scientifica (Cairo)., 2015, 613089 Sgueglia, 2015, One-year follow-up of patients treated with new-generation polymer-based 38mm everolimus-eluting stent: The P38 Study, CCI, 85, 218 Lesiak, 2016, Long Coronary lesions treated with thin strut bioresorbable polymer drug eluting stent: Experience from multicentre randomized CENTURY II Study, J Interv Cardiol., 29, 47, 10.1111/joic.12262 Choi, 2014, Impact of the stent length on long term clinical outcomes following newer-generation drug eluting stents implantation, Am J Cardiol., 113, 457e464, 10.1016/j.amjcard.2013.10.029